ORAMED appoints Dr. Simon Bruce as Vice President of Medical Affairs
July 18 2017 – ORAMED Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today the appointment of Dr. Simon Bruce MD to the newly created position
BioTime and CellCure open cGMP cell therapy manufacturing site in Israel
January 3, 2017 –BioTime and its majority-owned subsidiary, CellCure Neurosciences, opened a new, 800-m2 cGMP cell therapy manufacturing facility at the Jerusalem Bio Park, which is
Gamida Cell Announces $3.5 Million Grant from the Israeli Government
July 20 2017 – Jerusalem- based Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced
New partnership between Christiana Care’s Gene Editing Institute and NovellusDx aims to improve personalized cancer medicine
July 20 2017 – Personalized cancer therapies are on the horizon thanks to a new genomic cancer research partnership between the Gene Editing Institute of Christiana Care Health System’s Helen
The Aerodentis braces clinical trial sheds metal brackets
The Aerodentis braces has started new clinical trials at the University of Alabama at Birmingham School of Dentistry. The treatment, called Aerodentis, applies pulsating air through
Aeon Pharmaceuticals wins 1st place in the Pitch Competition of the Bio Executive Forum
Aeon Pharmaceuticals , a Jerusalem company, is developing a detoxification antidote to treat ER (Emergency Room) patients for alcohol poisoning. Alcohol abuse is a global epidemic.
BioFeed launched novel solutions for pest-control during PM’s Modi and Netanyahu visit
July 6 2017 – Biofeed launched a novel solution to the Bactrocera dorsalis and Bactrocera zonata fruit flies during a visit by Indian Prime Minister Modi and
Congratulations to Anan Copty, Butros Hallac, and NIMD on getting awarded a CIIRDF grant
NIMD, Non Invasive Medical Devices, a Jerusalem-based medical device startup company focused on the treatment of cancer, has been awarded a grant by the Canada-Israel
Gamida Cell Ltd closes today $40 million financing!
Jerusalem based Gamida Cell Ltd., a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today that they have
